Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9827230 Pharmaceutical compositions

Patent 9827230 was granted and assigned to Xspray Microparticles AB on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Xspray Microparticles AB

Current Assignee

Xspray Microparticles AB

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 28, 2017

Patent Application Number

15248107

Date Filed

August 26, 2016

Patent Citations Received

US Patent 12016861 Amorphous nilotinib microparticles and uses thereof

0

US Patent 12064428 Kinase inhibitor salts and compositions thereof

0

US Patent 12064430 Kinase inhibitor salts and compositions thereof

0

US Patent 11980619 Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses

0

US Patent 11998548 Amorphous nilotinib microparticles and uses thereof

0

0

Patent Primary Examiner

Jeffrey T. Palenik

Patent abstract

The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9827230 Pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool